ArticleFrontiers in bioengineering and biotechnology2025

An engineered adipose formulation decreases hepatic inflammation and fibrosis in a rodent model of metabolic dysfunction-associated steatotic liver disease.

Youngshim Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.